Rizedisben

DB21610InvestigationalSmall molecule

Rizedisben is a small molecule drug. Rizedisben is under investigation in clinical trial NCT04983862 (Fluorescent Imaging of Nerves with Illuminare-1 During Surgery). Rizedisben has a monoisotopic molecular weight of 519.22...

Mechanism: Pharmacologically active on Myelin basic protein and Myelin protein P0
Curator reviewed
Formula / weight: C₂₉H₃₃N₃O₄S · 519.66 g/mol (avg)
Code names: GE-3126

Resolves to

Compound

UNII6K6H6NY5V4CAS1311570-07-6ChEMBLCHEMBL5314483

Structure

InChIKeyUQCMMQGPTBKIAK-KHVHPYDTSA-NSMILESCOC1=C(\C=C\C2=CC=C(N)C=C2)C=CC(\C=C\C2=CC=C(C=C2)S(=O)(=O)N2CCN(CCO)CC2)=C1

Targets

P02686MBPP25189MPZ

What you can answer from here — as of September 13, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Rizedisben, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account